Skip to Main Content

Paper Details

Gene expression-based prediction of pazopanib efficacy in sarcoma.
Eur J Cancer
1
2022
Cancer, IGF1R, KDR, NTRK3, advanced cancer, advanced soft-tissue sarcoma, mRNA, patient, patients, pazopanib, rare cancers, receptor tyrosine kinase, receptor tyrosine kinase genes, sarcoma, tyrosine
Author NameAffiliation
Nikolas von BubnoffUniversity of Freiburg Medical Center, University of Freiburg, University Hospital of Schleswig-Holstein
Frederick KlauschenGermany Institute of Pathology, Charite - Universitatsmedizin Berlin, And Berlin Institute of Health, Ludwig Maximilians University Munich
Benedikt Brors
Benedikt Brors
Simon KreutzfeldtNational Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Albrecht StenzingerGermany Institute of Pathology, Heidelberg University Hospital
Peter HorakNational Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Daniel H??bschmannHeidelberg Institute for Stem Cell Technology and Experimental Medicine
Daniel H??bschmannHeidelberg Institute for Stem Cell Technology and Experimental Medicine
Stefan Fr??hlingNational Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
  • 1 - 10

Datasets